NiKang Therapeutics Announces Completion of $200 Million Series C
Bing Yao, Ph.D., former chief executive officer and chairman of Viela Bio, and Ting Jia, Ph.D., founder, and chief investment officer of Octagon Capital Advisors...
Category : Clinical Intelligence/Clinical Efficiency
Clinical Intelligence Leader Inteliquet™ Highlights RWD Analysis
Real World Data Utilizing Patient Matching Technology Suggests the Same Treatment Regimen Delivered in Different Sequences Results in Different Outcomes Inteliquet, highlighted today Real World...
Ciitizen and RARE-X Collaborate to Improve Clinical Efficiency
Partnership supports the long tail of rare diseases and breaking down data silos to accelerate treatments A collaboration between Ciitizen, a healthcare technology company that helps...
Clinical Intelligence Company Caribou Biosciences Adds New Member
Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that it has expanded its scientific advisory board (SAB) with the appointment of...
Healthcare Tech Report Recognizes Wolters Kluwer’s Karen Kobelski
Wolters Kluwer, Health, a leading global provider of trusted clinical technology and evidence-based solutions, today announced that Karen Kobelski, Vice President and General Manager for Clinical...
Iktos Collabs with Kadmon to Use AI for New Drug Design
Iktos, a company specializing in Artificial Intelligence for new drug design, today announced that it has entered into a Research Collaboration Agreement with Kadmon, a...
Medical Intelligence Platform Dr.Evidence Expands Sr. Leadership
Unveils New Identity Emblematic of Purpose: Accelerated Impact™ Dr.Evidence™, the leading medical intelligence platform for life sciences companies, today announced a slate of key commercial...
Huma Raises $130M Financing to Scale Digital Health Platform
The investment arms of leading health and technology companies, Bayer, Hitachi, Samsung, Sony Innovation Fund by IGV, Unilever and the PE fund HAT, are financing...
Interline Therapeutics Launches With $92 Million
Investment from Foresite Capital and ARCH Venture Partners will support platform development and therapeutic programs focused on inflammatory disease and cancer Interline Therapeutics, a Foresite...
Exscientia Announces Second Molecule Created Using AI
Second clinical molecule from Exscientia collaboration with Sumitomo Dainippon Pharma to begin Phase 1 trials in United States. Clinical study of DSP-0038, a dual targeted...